Revenue $11.08B, down 3.4% on a year earlier. Premium revenue $10.46B, down 3.5%. Diluted EPS $0.73 against $1.51.
| Q3 FY26 | Q2 FY26 | Q3 FY25 | Year over year | |
|---|---|---|---|---|
| Revenue | $11.08B | $10.87B | $11.48B | -3.4% |
| Operating income | $106.00M | $145.00M | $137.00M | -22.6% |
| Net income | $38.00M | $60.00M | $79.00M | -51.9% |
| Diluted EPS | $0.73 | $1.19 | $1.51 | |
| Operating cash flow | -$159.00M | -$294.00M | -$125.00M | |
| Capital expenditures | -$37.00M | -$30.00M | -$38.00M | |
| Free cash flow | -$196.00M | -$324.00M | -$163.00M |
| Q3 FY26 | Q3 FY25 | Year over year | |
|---|---|---|---|
| Premium revenue | $10.46B | $10.84B | -3.5% |
The week's biggest guidance misses, KPI surprises and one chart.
Stock Atlas, “Molina Healthcare (MOH) Q3 FY26 earnings: results and KPIs”, stockatlas.com/companies/MOH/earnings/2026-q3/, data as of 3 November 2026. Links to this page are welcome.
